AVCI, O. Et Al. 2023. Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats. Revista Española de Anestesiología y Reanimación , vol.70 .

AVCI, O., TAŞKIRAN, A. Ş., & GÜNDOĞDU, O., (2023). Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats. Revista Española de Anestesiología y Reanimación , vol.70.

AVCI, ONUR, AHMET ŞEVKİ TAŞKIRAN, And OĞUZ GÜNDOĞDU. "Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats," Revista Española de Anestesiología y Reanimación , vol.70, 2023

AVCI, ONUR Et Al. "Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats." Revista Española de Anestesiología y Reanimación , vol.70, 2023

AVCI, O. TAŞKIRAN, A. Ş. And GÜNDOĞDU, O. (2023) . "Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats." Revista Española de Anestesiología y Reanimación , vol.70.

@article{article, author={ONUR AVCI Et Al. }, title={Dexmedetomidine, an α2 agonist, increases the morphine analgesic effect and decreases morphine tolerance development by suppressing oxidative stress and TNF/IL-1 signalling pathway in rats}, journal={Revista Española de Anestesiología y Reanimación}, year=2023}